期刊文献+

信号传导与转录激活因子3和E-钙黏蛋白及波形蛋白在结肠癌组织中的表达及其临床意义 被引量:7

Clinical significance of signal transduction and activators of transcription 3, E-cadherin and vimentin in colon cancer
原文传递
导出
摘要 目的探讨信号传导与转录激活因子3(STAT3)和E-钙黏蛋白(E—cadherin)及波形蛋白(vimentin)在结肠癌组织中的表达及其临床意义。方法收集70例结肠癌患者结肠癌组织和相应癌旁组织标本.应用免疫组织化学方法检测STAT3、E-cadherin和vimentin的表达,分析其与结肠癌临床病理特征的关系及三者表达之间的相关性。结果STAT3、E-cadherin及vimentin在结肠癌组织中阳性表达分别为52例(74.3%)、23例(32.9%)和55例(78.6%),在癌旁组织阳性表达分别为13例(15.7%)、58例(82.9%)和9例(12.9%),差异均有统计学意义(均P〈0.01)。STAT3、E-cadherin及vimentin的表达均与肿瘤分化程度、浸润深度、淋巴结转移及TNM分期有关(均P〈0.05)。STAT3表达与vimentin表达呈正相关.而与E-cadherin表达呈负相关(均P〈0.01)。结论STAT3、E-cadherin及vimentin与结肠癌关系密切,其表达水平可作为判断结肠癌病程和预后的参考指标之一. Objective To evaluate the clinical significance of STAT3, E-cadherin and vimentin in colon cancer. Methods Samples of colon cancer tissue and adjacent normal tissue were procured from 70 patients with colon cancer. The expressions of STAT3, E-eadherin and vimentin were detected by immunohistochemistry. Associations of clinicopathologieal characteristics and these three factors were evaluated. Results STAT3, E-cadherin, vimentin were positive in 74.3%,32.9%, and 78.6% in the colon cancer tissues, respectively, and were 15.7%, 82.9%, and 12.9% in normal colon mucosa tissues, respectively. They were correlated with tumor differentiation, depth of invasion, lymph node metastasis, and TNM staging (P〈0.05). There was a positive correlation between STAT3 and vimentin expression (P〈0.01). However, STAT3 was negatively correlated with E-cadherin (P〈0.01). Conclusions STAT3, E-cadherin and vimentin are closely associated with colon cancer. The expressions of STAT3, E-cadherin and vimentin may serve as prognostic indicators for patients with colon cancer.
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第3期202-205,共4页 Chinese Journal of Gastrointestinal Surgery
基金 全军医学科研“十一五”计划面上项目(06MB243)
关键词 结肠肿瘤 信号传导与转录激活因子3 E-钙黏蛋白 波形蛋白 Colonic neoplasms Signal transduction and activators of transcription 3 E-eadherin Vimentin
  • 相关文献

参考文献13

  • 1Yu H, Jove R. The stats of cancer-New molecular targets come of age. Nat Rev Cancer, 2004,4(2) :97-105. 被引量:1
  • 2徐建华,张超,唐波,郝迎学,陈军,刘涛,崔浩.JAK2-STAT3-波形蛋白信号通路对结肠癌细胞增殖迁移的影响[J].中华胃肠外科杂志,2010,13(4):282-285. 被引量:3
  • 3Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys ResCommun, 2009,384(1):6-11. 被引量:1
  • 4许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 5Lassmann S, Schuster I, Walch A, et al. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3inducible targets linked to cell survival and proliferation. J Clin Pathol, 2007,60(2) : 173-179. 被引量:1
  • 6陈维香,费绍华,祝蕾,丁珺,伍健.结直肠癌组织中钙黏附素表达与淋巴结微转移的关系[J].中华胃肠外科杂志,2010,13(4):300-301. 被引量:2
  • 7Mohammadizadeh F, Ghasemibasir H, Rajabi P, et al. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma. Cancer Biomark, 2009,5(1) : 1-8. 被引量:1
  • 8Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumor progression : an alliance against the epithelial phenotype? Nat Rev Cancer, 2007,7(6):415-428. 被引量:1
  • 9Yamashita S, Miyagi C, Fukada T, et al. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrulaorganizer. Nature, 2004,429 (6989) : 298-302. 被引量:1
  • 10Ivaska J, Pallari HM, Nero J, et al. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res, 2007,313 (10) : 2050-2062. 被引量:1

二级参考文献16

共引文献1370

同被引文献81

  • 1张云锋,赵阳,任宏.JAK激酶抑制剂AG490阻滞乳腺癌MCF-7的侵袭和迁移[J].西安交通大学学报(医学版),2012,33(5):564-567. 被引量:2
  • 2J 萨姆布鲁克,EF 弗里奇,T 曼尼阿蒂斯,等.分子克隆实验指南[M].3版.北京:科学出版社,2002,19. 被引量:34
  • 3Jennifer Dien,Hesham M,Amin, et al. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-I ex- pression and decreases invasiveness of breast cancer[J]. Am J Pathol, 2006,169 : 633-642. 被引量:1
  • 4Baranwal S,Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer[J]. Biochem Biophys Res Commun ,2009,384 (1):6-11. 被引量:1
  • 5Shak S.Overview of the trastuzmab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer.Herceptin Multinational Investigator Study Group[J]. Semin Oncol, 1999,26(4 Suppl 12) :71 -77. 被引量:1
  • 6Maria I Kokkinos,Razan Wafai,Meng Kang Wong,et al. Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo[J]. Cells Tissues Organs, 2007,185 ( 1-3 ) : 191-203. 被引量:1
  • 7Thiery JP. Epithelial-mesenchymal transitions in development and pathologies[J]. Curr Opin Cell Bio1,2003,15(6): 740-746. 被引量:1
  • 8Levy DE,Darnell JE Jr. Stats: transcriptional control and biological im- pact[J]. Nat Rev Mol Cell Biol,2002, 3(9):651-662. 被引量:1
  • 9Xie TX, Wei D,Liu M,et al. Sawava R, Huana S. Star3 activation reg-ulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis[J]. Oncogene, 2004,23 (20) : 3550-3560. 被引量:1
  • 10Colomiere M, Ward AC, Riley C,e! al. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchy- mal transition in ovarian carcinomas[J]. Br J Cancer, 2009, 100(1 ) : 134- 144. 被引量:1

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部